252 related articles for article (PubMed ID: 34771618)
21. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.
Thick J; Metcalfe JA; Mak YF; Beatty D; Minegishi M; Dyer MJ; Lucas G; Taylor AM
Oncogene; 1996 Jan; 12(2):379-86. PubMed ID: 8570215
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic interception in T-cell leukemia 1A associated pathways as a treatment rationale for chronic lymphocytic leukemia.
Popal W; Boucas J; Peer-Zada AA; Herling M
Leuk Lymphoma; 2010 Aug; 51(8):1375-8. PubMed ID: 20687795
[TBL] [Abstract][Full Text] [Related]
23. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family.
Laine J; Künstle G; Obata T; Noguchi M
J Biol Chem; 2002 Feb; 277(5):3743-51. PubMed ID: 11707444
[TBL] [Abstract][Full Text] [Related]
25. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
Johnston HE; Carter MJ; Cox KL; Dunscombe M; Manousopoulou A; Townsend PA; Garbis SD; Cragg MS
Mol Cell Proteomics; 2017 Mar; 16(3):386-406. PubMed ID: 28062796
[TBL] [Abstract][Full Text] [Related]
26. The murine Tcl1 oncogene: embryonic and lymphoid cell expression.
Narducci MG; Virgilio L; Engiles JB; Buchberg AM; Billips L; Facchiano A; Croce CM; Russo G; Rothstein JL
Oncogene; 1997 Aug; 15(8):919-26. PubMed ID: 9285687
[TBL] [Abstract][Full Text] [Related]
27.
Ho MF; Lummertz da Rocha E; Zhang C; Ingle JN; Goss PE; Shepherd LE; Kubo M; Wang L; Li H; Weinshilboum RM
J Pharmacol Exp Ther; 2018 Jun; 365(3):700-710. PubMed ID: 29592948
[TBL] [Abstract][Full Text] [Related]
28. Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity.
McCaffrey TA; Tziros C; Lewis J; Katz R; Siegel R; Weglicki W; Kramer J; Mak IT; Toma I; Chen L; Benas E; Lowitt A; Rao S; Witkin L; Lian Y; Lai Y; Yang Z; Fu SW
Int J Biol Sci; 2013; 9(4):350-60. PubMed ID: 23630447
[TBL] [Abstract][Full Text] [Related]
29.
Ho MF; Ingle JN; Bongartz T; Kalari KR; Goss PE; Shepherd LE; Mushiroda T; Kubo M; Wang L; Weinshilboum RM
Mol Pharmacol; 2017 Aug; 92(2):175-184. PubMed ID: 28615284
[TBL] [Abstract][Full Text] [Related]
30. Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes.
Urbankova H; Baens M; Michaux L; Tousseyn T; Rack K; Katrincsakova B; Ferreiro JF; van Loo P; de Kelver W; Dierickx D; Demuynck H; Delannoy A; Verschuere J; Jarošová M; de Wolf-Peeters C; Vandenberghe P; Wlodarska I
Leuk Lymphoma; 2012 Dec; 53(12):2449-55. PubMed ID: 22553924
[TBL] [Abstract][Full Text] [Related]
31. T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature.
Sugimoto KJ; Shimada A; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(5):2615-23. PubMed ID: 24966976
[TBL] [Abstract][Full Text] [Related]
32. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
López C; Bergmann AK; Paul U; Murga Penas EM; Nagel I; Betts MJ; Johansson P; Ritgen M; Baumann T; Aymerich M; Jayne S; Russell RB; Campo E; Dyer MJ; Dürig J; Siebert R
Br J Haematol; 2016 Apr; 173(2):265-73. PubMed ID: 26917488
[TBL] [Abstract][Full Text] [Related]
33. Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.
Punt S; Corver WE; van der Zeeuw SA; Kielbasa SM; Osse EM; Buermans HP; de Kroon CD; Jordanova ES; Gorter A
Oncotarget; 2015 Nov; 6(36):38681-94. PubMed ID: 26299617
[TBL] [Abstract][Full Text] [Related]
34. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.
Narducci MG; Virgilio L; Isobe M; Stoppacciaro A; Elli R; Fiorilli M; Carbonari M; Antonelli A; Chessa L; Croce CM; Russo G
Blood; 1995 Sep; 86(6):2358-64. PubMed ID: 7662982
[TBL] [Abstract][Full Text] [Related]
35. The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
Despouy G; Joiner M; Le Toriellec E; Weil R; Stern MH
Blood; 2007 Dec; 110(13):4406-16. PubMed ID: 17846228
[TBL] [Abstract][Full Text] [Related]
36. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q.
Garding A; Bhattacharya N; Haebe S; Müller F; Weichenhan D; Idler I; Ickstadt K; Stilgenbauer S; Mertens D
Haematologica; 2013 Feb; 98(2):269-73. PubMed ID: 22875623
[TBL] [Abstract][Full Text] [Related]
37. Targeting CK2-driven non-oncogene addiction in B-cell tumors.
Mandato E; Manni S; Zaffino F; Semenzato G; Piazza F
Oncogene; 2016 Nov; 35(47):6045-6052. PubMed ID: 27041560
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins.
Auguin D; Barthe P; Royer C; Stern MH; Noguchi M; Arold ST; Roumestand C
J Biol Chem; 2004 Aug; 279(34):35890-902. PubMed ID: 15169787
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
[TBL] [Abstract][Full Text] [Related]
40. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
